190 related articles for article (PubMed ID: 5535268)
1. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
Mackler MA; Liberti JP; Smith MJ; Prout GR
Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
[No Abstract] [Full Text] [Related]
2. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
[No Abstract] [Full Text] [Related]
3. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)].
Straube W; Braun JS
Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442
[No Abstract] [Full Text] [Related]
4. Medical castration with megestrol acetate and minidose of diethylstilbestrol.
Geller J; Albert J; Yen SS; Geller S; Loza D
Urology; 1981 Apr; 17(4 Suppl):27-33. PubMed ID: 6782738
[No Abstract] [Full Text] [Related]
5. [Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy].
Peyromaure M; Rebillard X; Ruffion A; Salomon L; Villers A; Soulie M;
Prog Urol; 2008 Jan; 18(1):2-8. PubMed ID: 18342148
[TBL] [Abstract][Full Text] [Related]
6. Plasma testosterone in patients receiving diethylstilbestrol.
Beck PH; McAnich JW; Goebel JL; Stutzman RE
Urology; 1978 Feb; 11(2):157-60. PubMed ID: 628992
[TBL] [Abstract][Full Text] [Related]
7. The question of stilbestrol in the treatment of prostatic carcinoma.
Lawrence W; Horsley JS
Va Med Mon (1918); 1968 Apr; 95(4):238-40. PubMed ID: 5645075
[No Abstract] [Full Text] [Related]
8. Estrogen and survival data in carcinoma of the prostate.
Bennett AH; Dowd JB; Harrison JH
Surg Gynecol Obstet; 1970 Mar; 130(3):505-8. PubMed ID: 4905115
[No Abstract] [Full Text] [Related]
9. High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens.
Band PR; Banerjee TK; Patwardhan VC; Eid TC
Can Med Assoc J; 1973 Oct; 109(8):697-9. PubMed ID: 4746128
[TBL] [Abstract][Full Text] [Related]
10. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
[TBL] [Abstract][Full Text] [Related]
11. Estrogens and cancer of the prostate.
Kaplan L
Surg Gynecol Obstet; 1969 Jan; 128(1):117. PubMed ID: 5774991
[No Abstract] [Full Text] [Related]
12. [Testosterone serum concentrations after subcapsular orchiectomy (author's transl)].
Senge T; Hülshoff T; Tunn U; Schenck B; Neumann F
Urologe A; 1978 Nov; 17(6):382-4. PubMed ID: 726161
[TBL] [Abstract][Full Text] [Related]
13. [Diethyl-stilbestrol for treatment of prostatic carcinoma].
Cifuentes Delatte L
Arch Esp Urol; 1990 Sep; 43(7):697-704. PubMed ID: 2125823
[No Abstract] [Full Text] [Related]
14. Treatment of advanced carcinoma of the prostate.
Blackard CE
Surg Gynecol Obstet; 1971 Jul; 133(1):97-8. PubMed ID: 5091832
[No Abstract] [Full Text] [Related]
15. Low-dose cyproterone acetate plus mini-dose diethylstilbestrol--a protocol for reversible medical castration.
Goldenberg SL; Bruchovsky N; Gleave ME; Sullivan LD
Urology; 1996 Jun; 47(6):882-4. PubMed ID: 8677581
[TBL] [Abstract][Full Text] [Related]
16. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
17. The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.
Jeromin L
Int Urol Nephrol; 1982; 14(1):51-6. PubMed ID: 6889585
[TBL] [Abstract][Full Text] [Related]
18. Bilateral orchiectomy for carcinoma of prostate. Response of serum testosterone and clinical response to subsequent estrogen therapy.
Klugo RC; Farah RN; Cerny JC
Urology; 1981 Jan; 17(1):49-50. PubMed ID: 7456197
[TBL] [Abstract][Full Text] [Related]
19. Management of prostate carcinoma.
Whitehead ED
N Y State J Med; 1981 Sep; 81(10):1481-5. PubMed ID: 7024862
[No Abstract] [Full Text] [Related]
20. Re: Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm.
Guess B; Scholz M
J Urol; 2001 May; 165(5):1644-5. PubMed ID: 11345950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
